1. Home
  2. PBYI vs FRGE Comparison

PBYI vs FRGE Comparison

Compare PBYI & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • FRGE
  • Stock Information
  • Founded
  • PBYI 2010
  • FRGE 2014
  • Country
  • PBYI United States
  • FRGE United States
  • Employees
  • PBYI N/A
  • FRGE N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • FRGE Computer Software: Prepackaged Software
  • Sector
  • PBYI Health Care
  • FRGE Technology
  • Exchange
  • PBYI Nasdaq
  • FRGE Nasdaq
  • Market Cap
  • PBYI 237.2M
  • FRGE 262.8M
  • IPO Year
  • PBYI N/A
  • FRGE N/A
  • Fundamental
  • Price
  • PBYI $5.41
  • FRGE $17.28
  • Analyst Decision
  • PBYI Strong Buy
  • FRGE Buy
  • Analyst Count
  • PBYI 1
  • FRGE 5
  • Target Price
  • PBYI $7.00
  • FRGE $35.50
  • AVG Volume (30 Days)
  • PBYI 511.9K
  • FRGE 73.8K
  • Earning Date
  • PBYI 11-06-2025
  • FRGE 11-05-2025
  • Dividend Yield
  • PBYI N/A
  • FRGE N/A
  • EPS Growth
  • PBYI 434.29
  • FRGE N/A
  • EPS
  • PBYI 0.97
  • FRGE N/A
  • Revenue
  • PBYI $238,062,000.00
  • FRGE $90,840,000.00
  • Revenue This Year
  • PBYI N/A
  • FRGE $32.56
  • Revenue Next Year
  • PBYI N/A
  • FRGE $21.75
  • P/E Ratio
  • PBYI $5.56
  • FRGE N/A
  • Revenue Growth
  • PBYI 8.63
  • FRGE 14.78
  • 52 Week Low
  • PBYI $2.32
  • FRGE $6.60
  • 52 Week High
  • PBYI $6.07
  • FRGE $24.90
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 65.34
  • FRGE 51.12
  • Support Level
  • PBYI $5.11
  • FRGE $16.15
  • Resistance Level
  • PBYI $5.42
  • FRGE $17.00
  • Average True Range (ATR)
  • PBYI 0.25
  • FRGE 0.98
  • MACD
  • PBYI 0.06
  • FRGE 0.25
  • Stochastic Oscillator
  • PBYI 75.36
  • FRGE 46.48

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About FRGE Forge Global Holdings Inc.

Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.

Share on Social Networks: